免疫化學市場規模：按技術、按應用、按最終用戶、按地區、範圍和預測

免疫化學市場規模及預測

2023年免疫化學市場規模為33.4億美元，預計2024年至2031年複合年增長率為7.1%，2031年達57.8億美元。免疫化學是研究免疫系統的分子機制和反應的化學分支，特別強調抗體、抗原的結構和功能及其相互作用。結合免疫學和生物化學的原理和技術，我們對抗原如何激活免疫反應，以及抗體如何產生並發揮作用來中和感染和異物有更好的瞭解。在治療學中，免疫化學為單株抗體的開發鋪平了道路，單株抗體可用作多種疾病的標靶治療藥物，包括自體免疫疾病和惡性腫瘤。

此外，免疫化學原理在疫苗開發中發揮重要作用，可以設計出誘導免疫反應並預防傳染病的疫苗。

全球免疫化學市場動態

主要市場推動因素

慢性病盛行率上升：

全球癌症、心血管疾病和自體免疫疾病等慢性疾病的增加增加了對免疫化學診斷的需求。這些診斷對於這些疾病的早期檢測、監測和管理至關重要，也是市場擴張的驅動力。

技術進步：

免疫測定和抗體工程的創新提高了免疫化學測試的敏感度、特異性和速度。因此，自動化免疫分析系統和高通量篩選能力可實現更有效率、更準確的診斷過程，進而推動市場成長。

對個人化醫療的需求不斷增長：

個人化醫療的轉變需要根據個人的基因組成進行準確的診斷和治療，這正在推動免疫化學市場的發展。免疫化學對於尋找生物標記和將治療與特定患者資料相匹配非常重要。

醫療保健支出和意識不斷提高：

醫療支出的增加和預防醫學知識的提高正在推動免疫化學診斷在已開發國家和新興國家的使用。鼓勵早期發現疾病和健康檢查的政府措施和醫療保健立法正在推動市場成長。

主要課題

先進免疫化學技術成本高：

開發和維護現代免疫化學設備和試劑成本高。這種高成本對小型實驗室和醫療機構（尤其是發展中國家）構成了重大障礙，限制了尖端免疫化學診斷的採用和使用。

與替代技術的競爭：

免疫化學測試市場日益受到替代診斷技術的威脅，例如分子診斷和下一代定序，這些技術提供更快、更準確的測試。繼續適應這些技術，同時保持成本效率和準確性是市場的主要障礙。

缺乏熟練的專業人員：

操作現代免疫化學設備和解釋測試結果需要高技能的人員。全球範圍內該領域缺乏熟練的醫療保健人員，限制了免疫化學診斷的有效使用和發展。

主要趨勢

檢測系統自動化與整合：

免疫化學實驗室的自動化趨勢正在提高效率、減少人力錯誤並提高生產力。包含多種診斷技術的整合系統變得越來越流行，提供全面的解決方案，加快工作流程並提高診斷準確性。

擴大即時檢測 (POCT)：

在標準實驗室之外提供快速結果的即時免疫化學測試的需求不斷增長。此類測試在診所、急診室和家庭醫療機構中變得越來越普遍，從而可以更快地做出住院護理決策。

開發高靈敏度和多重檢測：

免疫化學的進步使得開發更靈敏且可以同時（多重）檢測多個標靶的檢測方法成為可能。這提高了早期診斷疾病並以較小的樣本量執行複雜分析的能力。

專注於生物標記發現和伴隨診斷：

免疫化學市場越來越關注新生物標記的發現和伴隨診斷的開發。這些診斷對於個人化醫療至關重要，因為它們能夠根據與疾病預後和治療效果相關的特定生物標記來客製化治療方法。

目錄

第1章簡介

• 市場定義
• 市場細分
• 調查方法

第 2 章執行摘要

• 主要發現
• 市場概況
• 市集亮點

第3章市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場驅動力
• 市場制約因素
• 市場機會
• 波特五力分析

第4章免疫化學市場：依技術分類

• 酶聯免疫吸附測定 (ELISA)
• 放射免疫分析（RIA）
• 化學發光免疫分析 (CLIA)
• 螢光免疫測定法 (FIA)
• 免疫印跡

第5章免疫化學市場：依應用分類

• 傳染病測試
• 腫瘤學
• 自身免疫性疾病
• 內分泌學
• 心臟病學
• 過敏測試
• 治療藥物監測

第6章免疫化學市場：依最終用戶分類

• 醫院和診所
• 診斷實驗室
• 學術/研究機構
• 生物技術和製藥公司
• 血庫
• 護理點 (POC) 測試設施

第7章區域分析

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東/非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合酋長國

第8章市場動態

• 市場驅動力
• 市場制約因素
• 市場機會
• COVID-19 的市場影響

第9章 競爭格局

• 大公司
• 市場佔有率分析

第10章 公司簡介

• Roche Diagnostics（Switzerland）
• Abbott Laboratories（US）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• Danaher Corporation（US）
• Sysmex Corporation（Japan）
• Ortho Clinical Diagnostics（US）
• Bio-Rad Laboratories, Inc.（US）
• MeridianBioscience, Inc.（US）
• Fujifilm Holdings Corporation（Japan）
• LumiraDx（UK）
• QuidelOrtho Corporation（US）
• DiaSorin SpA（Italy）

第11章市場前景與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章附錄

• 縮寫表
• 來源和參考文獻

Immunochemistry Market Size And Forecast

Immunochemistry Market size was valued at USD 3.34 Billion in 2023 and is projected to reach USD 5.78 Billion by 2031, growing at a CAGR of 7.1% from 2024 to 2031. Immunochemistry is a branch of chemistry that studies the molecular mechanisms and reactions of the immune system, with a special emphasis on the structure and function of antibodies, antigens, and their interactions. It combines immunological and biochemical principles and techniques to better understand how antigens activate immune responses, as well as how antibodies are created and operate to neutralize infections or foreign substances. In therapeutics, immunochemistry has led the way for the development of monoclonal antibodies that are used as targeted treatments for a variety of disorders, including autoimmune diseases and malignancies, by harnessing the body's immune system to combat the disease.

Furthermore, immunochemical principles play an important role in vaccine development, allowing for the design of vaccines that trigger an immune response and protect against infectious diseases.

Global Immunochemistry Market Dynamics

The key market dynamics that are shaping the immunochemistry market include:

Key Market Drivers

Rising Prevalence of Chronic Diseases:

The rising global frequency of chronic illnesses such as cancer, cardiovascular disease, and autoimmune disorders is driving demand for immunochemistry diagnostics. These diagnostics are crucial for the early detection, monitoring, and management of such diseases, which helps to drive market expansion.

Advancements in Technology:

Technological breakthroughs in immunoassays and antibody engineering have improved the sensitivity, specificity, and speed of immunochemistry testing. Thus, automated immunoassay systems and high-throughput screening capabilities allow for more efficient and accurate diagnostic processes, which drives market growth.

Growing Demand for Personalized Medicine:

The shift towards personalized medicine, which necessitates precise diagnosis and therapy based on individual genetic makeup, is driving the immunochemistry market. Immunochemistry is critical in finding biomarkers and adapting therapy to specific patient profiles.

Increased Healthcare Expenditure and Awareness:

Rising healthcare spending and growing knowledge about preventive healthcare in both established and emerging nations drive up the utilization of immunochemistry diagnostics. Government initiatives and healthcare legislation that encourage early disease identification and health screenings bolster market growth.

Key Challenges:

High Cost of Advanced Immunochemistry Technologies:

The development and maintenance of modern immunochemistry devices and reagents are costly. This high cost poses a substantial obstacle for small-scale laboratories and healthcare facilities, particularly in developing countries, limiting the adoption and availability of cutting-edge immunochemistry diagnostics.

Competition from Alternative Technologies:

The immunochemistry market is gradually being challenged by alternative diagnostic technologies such as molecular diagnostics and next-generation sequencing, which provide faster and more accurate testing choices. Keeping up with these technologies while being cost-effective and accurate is an enormous obstacle to the market.

Lack of Skilled Professionals:

The operation of modern immunochemistry equipment and the interpretation of test results necessitate highly skilled personnel. There is a global dearth of skilled healthcare personnel in this field, limiting the effective use and growth of immunochemistry diagnostics.

Key Trends:

Automation and Integration of Laboratory Systems:

The trend towards automation in immunochemistry laboratories is improving efficiency, lowering manual errors, and increasing productivity. Integrated systems that incorporate many diagnostic technologies are becoming increasingly popular, providing comprehensive solutions that expedite workflows and increase diagnostic accuracy.

Expansion of Point-of-Care Testing (POCT):

There is an increasing demand for point-of-care immunochemistry assays that provide quick results outside of standard laboratory settings. These tests are becoming increasingly common in clinics, emergency rooms, and home care settings, allowing for more prompt decision-making in inpatient treatment.

Development of High-Sensitivity and Multiplex Assays:

Advances in immunochemistry are enabling the development of assays with greater sensitivity and the ability to detect numerous targets at the same time (multiplexing). This improves the ability to diagnose diseases at an early stage and conduct complicated analyses with a small sample volume.

Focus on Biomarker Discovery and Companion Diagnostics:

The immunochemistry market is increasingly focused on discovering new biomarkers and developing companion diagnostics. These diagnostics are crucial for personalized medicine, as they allow for tailored treatment approaches based on specific biomarkers associated with disease prognosis and treatment response.

Global Immunochemistry Market Regional Analysis

Here is a more detailed regional analysis of the immunochemistry market:

North America:

According to Verified Market Research, North America is estimated to dominate the immunochemistry market during the forecast period. North America, particularly the United States, has a highly advanced healthcare infrastructure with extensive use of cutting-edge medical technologies. This infrastructure enables the widespread use of immunochemistry diagnostics in clinical laboratories and hospitals, contributing to the region's market supremacy.

The region's strong emphasis on R&D, which is funded by both public and commercial financing, drives innovation in immunochemistry diagnostics. This investment leads to the development of new and improved diagnostic tests and technologies, which fuels the market's expansion.

Chronic diseases such as cancer, cardiovascular disease, and autoimmune problems are prevalent in North America. The region's leadership in the immunochemistry market is mostly due to the necessity for precise and timely diagnoses to successfully manage these diseases.

Furthermore, in North America, comprehensive regulatory policies and favorable reimbursement situations ensure that sophisticated immunochemistry diagnostics are available and affordable. This motivates healthcare providers to use these technologies, boosting market growth in the region.

Asia Pacific:

The Asia Pacific region's huge and fast-growing population, along with an ageing population, considerably contributes to the rising demand for healthcare services, particularly immunochemistry diagnostics, to manage chronic and age-related disorders.

Many Asian Pacific countries are investing considerably in enhancing their healthcare infrastructure, such as expanding healthcare facilities and laboratories equipped with new diagnostic tools. This improvement is critical for increasing the accessibility and usage of immunochemistry diagnostics.

Furthermore, the region's population is becoming increasingly aware of the necessity of early disease identification and preventive healthcare. This increased awareness is pushing up demand for immunochemistry diagnostics, which are critical for early and accurate illness detection.

Europe:

European countries typically spend a significant portion of their GDP on healthcare. Government funding and support for healthcare systems, especially reimbursement rules for diagnostic tests, have a substantial impact on the regional immunochemistry market's growth.

Chronic diseases such as cancer, diabetes, and cardiovascular disease impose a huge burden on Europe. The necessity for early identification, precise diagnosis, and continued monitoring of these circumstances promotes regional demand for immunochemistry diagnostics.

Furthermore, in Europe, there is a growing movement towards personalized medicine, tailoring therapies to unique patient characteristics. Immunochemistry diagnostics are critical for finding biomarkers for personalized treatment strategies, driving their widespread usage in healthcare settings across the region.

Global Immunochemistry Market: Segmentation Analysis

The Immunochemistry Market is segmented based on Technology, Application, End-user Industry And Geography.

Immunochemistry Market, By Technology

• Enzyme-linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Western Blotting
• Others

Based on Technology, the market is segmented into ELISA, RIA, CLIA, FIA, Western Blotting and Others. The enzyme-linked immunosorbent assay (ELISA) segment is estimated to dominate the immunochemistry market due to its diverse uses in illness diagnosis, which include infectious disorders, cancer, autoimmune diseases, and endocrinology. It is widely used because of its specificity, sensitivity, and adaptability in detecting and measuring molecules such as peptides, proteins, antibodies, and hormones. Furthermore, ELISA's low cost, convenience of use, and capacity to process a large number of samples at once make it a popular choice for laboratories and research organizations around the world.

Immunochemistry Market, By Application

• Oncology
• Cardiology
• Endocrinology
• Allergy Testing
• Testing for Infectious Disorders
• Autoimmune Disorders
• Therapeutic Drug Monitoring
• Others

Based on Application, the market is segmented into Oncology, Cardiology, Endocrinology, Allergy Testing, Testing for Infectious Disorders, Autoimmune Disorders, Therapeutic Drug Monitoring and Others. The oncology segment is estimated to dominate the immunochemistry market during the forecast period due to the increasing global cancer incidence and the crucial need for early detection, diagnosis, and monitoring of diverse cancer kinds. Immunochemistry is essential for detecting specific cancer biomarkers, allowing healthcare practitioners to personalize treatment approaches more effectively. Furthermore, recent advancements in immuno-oncology research majorly focuses on understanding and utilizing the immune system to combat cancer, thereby, driving up demand for immunochemistry diagnostics in oncology.

Immunochemistry Market, By End-User

• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Others

Based on the End-User, the immunochemistry market is divided into Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies and Others. The hospitals & clinics segment is estimated to dominate the market over the forecast period. This dominance is attributed to the crucial role hospitals and clinics play in patient care, which includes diagnosis, treatment, and monitoring for various ailments. These healthcare facilities are the key points of contact for people seeking medical attention, including those who require immunochemistry testing for malignancies, autoimmune illnesses, and infectious infections.

Immunochemistry Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the immunochemistry market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the market during the forecasted period. The region, particularly the United States, has a well-established, modern healthcare infrastructure, allowing for widespread access to sophisticated diagnostic tools such as immunochemistry. North America has a significant concentration of prominent biotechnology and pharmaceutical businesses that invest heavily in R&D, fueling innovation in immunochemistry diagnostics. The region also benefits from a solid regulatory framework and significant healthcare spending, which encourages the use of sophisticated healthcare solutions.

Key Players

• The "Immunochemistry Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Abbott Laboratories, Agilent Technologies, Akoya Biosciences, AstraZeneca, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina, Leica Biosystems, Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Roche Diagnostics International Ltd, Sakura Finetek USA, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Ventana Medical Systems and Waters Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Immunochemistry Market Recent Developments
• In 2022, F. Hoffmann-La Roche dominates the South African immunochemistry market, highlighting the importance of these diagnostic instruments in healthcare.
• In March 2021, Immunochemistry Technologies (ICT) announced a collaboration with Aves Labs' family of companies. This development combines ICT's expertise in custom immunoassay services and a patented range of ELISA reagents with Aves Labs' specialized emphasis, thereby expanding their offerings in the biotech business.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Immunochemistry Market, By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Western Blotting

5. Immunochemistry Market, By Application

• Testing for Infectious disorders
• Oncology
• Autoimmune Disorders
• Endocrinology
• Cardiology
• Allergy Testing
• Therapeutic Drug Monitoring

6. Immunochemistry Market, By End User

• Hospitals and Clinics
• Diagnostic laboratories
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Blood Banks
• Point-of-Care (POC) Testing Locations

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Roche Diagnostics (Switzerland)
• Abbott Laboratories (US)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Sysmex Corporation (Japan)
• Ortho Clinical Diagnostics (US)
• Bio-Rad Laboratories, Inc. (US)
• MeridianBioscience, Inc. (US)
• Fujifilm Holdings Corporation (Japan)
• LumiraDx (UK)
• QuidelOrtho Corporation (US)
• DiaSorin SpA (Italy)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References